Justin Fairchild
Corporate Officer/Principal at PORTAGE BIOTECH INC.
Profile
Justin Fairchild is currently working as Vice President-Development at Portage Biotech, Inc. and Vice President-Clinical Development at The Parker Institute For Cancer Immunotherapy.
He completed his undergraduate degree from Colgate University and his graduate degree from Johns Hopkins Bloomberg School of Public Health.
Justin Fairchild active positions
Companies | Position | Start |
---|---|---|
PORTAGE BIOTECH INC. | Corporate Officer/Principal | 18/08/2022 |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Chief Tech/Sci/R&D Officer | - |
Training of Justin Fairchild
Johns Hopkins Bloomberg School of Public Health | Graduate Degree |
Colgate University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PORTAGE BIOTECH INC. | Health Technology |
Private companies | 1 |
---|---|
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
- Stock Market
- Insiders
- Justin Fairchild